Capabilities
Emil operates three specialized units dedicated to Oral Solid, Liquid, and Topical lines, accredited by various global regulatory bodies. With a team of 400+ skilled professionals, we ensure quality-driven manufacturing across Rx, Nutraceutical, and OTC products.
Each unit is equipped with dedicated warehouses, core manufacturing and packaging areas, exclusive MAL & PAL entries with AHUs, in-house QC and microbiology labs, QA and technology transfer facilities, with integrated ERP-based systems.
Emil’s R&D is committed to improving affordability and accessibility of high-quality bioequivalent generics across major therapeutic areas such as cardiovascular diseases, diabetes, antibacterials, and pain management. We also address unmet needs by developing therapies that are more economical, effective, and patient-friendly.
Our dedicated team of F&D and ADL scientists has successfully conceptualized and executed complex formulations, continuously expanding our product basket. Each development is supported by robust clinical trials and bioequivalence studies, ensuring global standards of safety, efficacy, and quality.
At Emil, we are committed to strengthening our quality management systems across research and manufacturing, ensuring that every product, process, and facility meets the highest regulatory standards.
Our dedicated in-house QA team drives excellence through continuous training, robust quality management systems, thorough validation and qualifications, stringent vendor management, in-process quality assurance, and regular internal audits.
Please share your details below. We will reach out to understand how we can help you reach your business goals.